Skip to main content
. 2018 Mar 24;32(6):e22432. doi: 10.1002/jcla.22432

Table 1.

Pilot study. Women: Measured and calculated parameters in tertiles (T1‐T3) of serum creatinine

T1 (N = 52, 0.38‐0.79 mg/dL) T2 (N = 51, 0.79‐0.94 mg/dL) T3 (N = 52, 0.95‐6.65 mg/dL)
Age (y) 42.5 (33.5‐55.5) 50.0 (32.5‐61.0) 45.5 (37.5‐55.5)
Serum creatinine (mg/dL) 0.72 (0.66‐0.77) 0.86 (0.82‐0.89) 1.23 (1.02‐1.99)
CA125 (kU/L) 13.2 (8.9‐17.8) 11.6 (8.3‐17.9) 17.6 (11.1‐28.4)
HE4 (pmol/L) 52.6 (43.8‐70.0) 53.7 (45.6‐70.9) 142.0 (84.8‐2272.8)
ROMA (%) 8.5 (6.2‐14.8) 9.1 (5.9‐14.3) 39.6 (18.8‐68.0)

HE4, human epididymis protein 4; ROMA, Risk of Ovarian Malignancy Algorithm.

Divide by 0.01131 to convert creatinine from mg/dL to μmol/L. Data are given as median (interquartile range).